Clinical Outcomes of Patients (pts) with TP53-Mutated Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS): A Single Center Experience
Year: 2019
Type: conference-abstract
Source: Blood
Authors: Jan Philipp Bewersdorf, Rory M Shallis, Lohith Gowda, Karl Hager, Nikolai A. Podoltsev, Steven D. Gore, Thomas Prebet, Stephanie Halene, Iris Isufi, Francine M. Foss, Scott F. Huntington, Tae Kon Kim, Manoj M Pillai, Terri L Parker, Natalia Neparidze, Noffar Bar, Stuart Seropian, Alexa J. Siddon, Amer M. Zeidan
Institutions: Yale University, Yale Cancer Center, Yale New Haven Hospital
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2982797651
